| |
NOVA's core team of professional, administrative, and support staff have expertise in supporting government and non-government meetings and conferences. Below are summaries of some of our current or recent conference activities:
Community Networks Cancer Health Disparities Summit 2005 — July 18–20, 2005 Think Tank on Molecular Targets in Lymphoid Malignancies — August 24–26, 2005 Improving Colorectal Cancer Screening Delivery, Utilization, and Outcomes: The State of the Science — April 11–12, 2005 The First NCI Epidemiology Leadership Workshop: Tobacco, Diet, Genes — September 19–21, 2004 Cancer Health Disparities Summit 2004: Special Populations Networks — July 18–20, 2004 The New Jersey Governor's Conference on Effective Partnering in Cancer Research: Cancer Prevention and Control — May 16–18, 2004 Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application — May 20–21, 2004
Community Networks Cancer Health Disparities Summit 2005 — July 18–20, 2005
The Community Networks Cancer Health Disparities Summit 2005 is a three-day event that convenes cancer researchers, community partners, and others from diverse populations and disciplines to meet with NCI staff for the purpose of sharing experiences and discussing the principles and practices of cancer health research that directly benefits local communities. The Summit features both didactic lectures and interactive presentations on a variety of research topics by experts in their respective disciplines. This year's Summit responds to feedback from participants at previous Summits and lessons learned through the experiences of NCI-sponsored community-based initiatives, while focusing on the immediate needs of the Community Networks.
Think Tank on Molecular Targets in Lymphoid Malignancies — August 24–26, 2005
The Think Tank is cosponsored by the Office of Science Planning and Assessment and the Center for Cancer Research, National Cancer Institute; the Leukemia & Lymphoma Society; and the Multiple Myeloma Research Foundation to catalyze the discovery of novel therapeutic targets in the hematological malignancies and determine strategies to develop and deliver such molecularly targeted therapies to patients. The underlying assumption of the Think Tank is that an understanding of the pathogenesis of each form of hematological malignancy is the key to developing new therapies. While the conference will include introductory presentations concerning the current state of therapy for the hematological malignancies, most presentations will focus on emerging insights into the molecular pathogenesis of these cancers, as such insights may have potential therapeutic implications. The Think Tank will generate a written description highlighting the most promising avenues for therapeutic targeting in each of the hematological malignancies.
Improving Colorectal Cancer Screening Delivery, Utilization, and Outcomes: The State of the Science — April 11–12, 2005
Improving Colorectal Cancer Screening Delivery, Utilization, and Outcomes: The State of the Science, is a meeting that is being cosponsored by the National Cancer Institute (NCI) and Agency for Healthcare Research and Quality (AHRQ). It will take place April 11–12, 2005, at the AHRQ Conference Center in Rockville, Maryland.
Since December 2001, NCI and AHRQ have been collaborating to actively promote health services and behavioral research studies to improve colorectal cancer screening delivery and outcomes in primary care practice. This State of the Science meeting will provide a forum for learning about and discussing current findings from several innovative studies that have been funded under the NCI/AHRQ Colorectal Cancer Screening Initiative. In addition, panel sessions on evaluating new screening technologies and assessing progress toward and future directions in improving colorectal cancer screening delivery and outcomes will be held.
The First NCI Epidemiology Leadership Workshop: Tobacco, Diet, Genes — September 19–21, 2004
Principal Investigators of grants in the portfolio of the Epidemiology and Genetics Research Program (EGRP), Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), are invited to attend the first annual EGRP Scientific Grantee Meeting. Participation is by invitation only. The Workshop will focus on identifying barriers and gaps in cancer epidemiology related to the topics of focus, and facilitating the conduct of research in these areas. At the same time, the workshop will highlight the research achievements of EGRP grantees through poster sessions and the creation of an EGRP Research Compendium.
Cancer Health Disparities Summit 2004: Special Populations Networks — July 18–20, 2004
Summit 2004 celebrates the outstanding performance of the Special Populations Networks. With only eight months remaining in the five-year performance of the SPNs, we will reflect on what we set out to do in April 2000, challenges along the way, and the extent to which we are being successful in reaching our goals. We will examine those activities that worked well and are replicable, and what we learned from those activities that did not work well. Participants will have opportunities to share ideas, for dialogue during facilitated discussion periods, and for informal networking.
Junior Researchers and others will have the opportunity to enhance their knowledge of grant writing and grants administration during workshop sessions conducted by experts in those areas. Keynote addresses will be provided by two nationally known community health educators/advocates: Dr. Jessie Gruman, President and Executive Director of the Center for the Advancement of Health, Washington, DC, and Dr. Hesung Chun Koh, President and Editor, East Rock Institute, New Haven, Connecticut.
The Summit will conclude with a prospectus of our next steps. We will examine approaches for transition from the SPNs to the newly created Community Networks.
The New Jersey Governor's Conference on Effective Partnering in Cancer Research: Cancer Prevention and Control — May 16–18, 2004
Governor James E. McGreevey and William N. Hait, M.D., Ph.D., Director, The Cancer Institute of New Jersey; Associate Dean for Oncology Programs and Professor of Medicine, UMDNJ-Robert Wood Johnson Medical School, are joining to co-host The New Jersey Governor's Conference on Effective Partnering in Cancer Research. Scheduled for Sunday, May 16, through Tuesday, May 18, 2004, at the Hyatt Regency Jersey City in Jersey City, NJ, the theme of this year's conference is Cancer Prevention and Control.
The purpose of this invitation-only meeting is to bring together the world's leaders in academia and industry with government officials and legislators, in hopes of developing a plan for facilitating the movement of discoveries in cancer prevention and control to clinical implementation. The overall goal of the meeting is the production of a white paper outlining the challenges to prevention and control and identifying potential solutions. The format will follow that of last year's meeting, including an opening panel discussion followed by a series of small workshops focusing on key issues in prevention and control. Rather than presenting didactic presentations, this meeting is a roll-up-your-sleeves opportunity to work with leaders in the field. We have also built in significant time for informal interactions and networking that will take advantage of the proximity of the Statue of Liberty, Ellis Island, and nearby Manhattan. The Hyatt Jersey City sits right across the harbor from Manhattan and offers spectacular views of the city skyline.
Last year's meeting proved to be a tremendous success, and we expect this year's to follow suit.
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application — May 20–21, 2004
A great deal of research has recently been published or is currently
underway to develop risk prediction models to accurately estimate the
absolute risk of cancer in average-risk individuals, as well as develop
models to estimate genetic susceptibility carrier status in high-risk
individuals.
The Cancer Risk Prediction Workshop has been planned to bring together experts in the emerging field of cancer risk prediction to:
Identify cancer risk prediction model applications and their usefulness in planning intervention trials, estimating the population burden of disease, creating benefit/risk indices and clinical decision making processes, and designing prevention strategies. Discuss the strengths and limitations of cancer risk prediction models in current use and under development. Discuss methodological issues relevant to the evaluation, validation, and discrimination of cancer risk prediction models. Identify ways to improve current and future cancer risk prediction models, incorporating new clinical, environmental, and genetic data. Identify research needs and population data resources for future cancer risk prediction modeling and validation and disseminate this information to the scientific community.
|
|
